• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human G antigen family C member 1 (PAGE4)

ACP21099

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP21099 Target NamePAGE4
Target SynonymsPAGE4; GAGEC1; JM27P antigen family member 4; PAGE-4; G antigen family C member 1; PAGE-1FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-102
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO60829
Background Information
  • Uniprot Id

    O60829

  • Target Species

    Human

  • Target Name

    PAGE4

  • Target Full Name

    P antigen family member 4

  • Target Function

    Intrinsically disordered protein that potentiates the transcriptional activator activity of JUN. Protects cells from stress-induced apoptosis by inhibiting reactive oxygen species (ROS) production and via regulation of the MAPK signaling pathway.

  • Target Subcellular Location

    Cytoplasm. Nucleus. Mitochondrion.

  • Target Protein Families

    GAGE family

  • Target Tissue Specificity

    Expressed at basal lvels in the adult normal prostate gland but is highly up-regulated in the fetal prostate and prostate cancer cells. Preferentially expressed in normal male and female reproductive tissues, testis, fallopian tube, uterus, and placenta,

  • Target Synonyms

    PAGE4; GAGEC1; JM27P antigen family member 4; PAGE-4; G antigen family C member 1; PAGE-1

Inquire Recombinant Human G antigen family C member 1 (PAGE4) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification